Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

BACKGROUND: Docetaxel and gemcitabine combinations have proven active for the treatment of non-small cell lung cancer (NSCLC). The aim of the present study was to evaluate and compare two treatment schedules, one based on our own preclinical data and the other selected from the literature. METHODS:...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Passardi, Alessandro, Cecconetto, Lorenzo, Dall'Agata, Monia, Dazzi, Claudio, Pasquini, Enzo, Oliverio, Giovanni, Zumaglini, Federica, Zoli, Wainer, Nanni, Oriana, Milandri, Carlo, Frassineti, Giovanni Luca, Amadori, Dino
格式: Artigo
語言:Inglês
出版: BioMed Central 2008
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2583994/
https://ncbi.nlm.nih.gov/pubmed/18976450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-65
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍